Interdisciplinary Working Group for Movement Disorders
Juergen Frevert, BSc, PhD
Scientist in BiochemistryAddress
14473 Potsdam
Contactjuergen.frevert@merz.de
Practice Areabiochemical projects e.g. for development of detections methods and vaccines for bacterial toxins & development of next generation botulinum toxin products with new pharmacological properties; immunological aspects of biologics; translational medicine
Special NotesDr. Juergen Frevert works as consultant for Merz Pharmaceuticals GmbH.
He studied chemistry at the Philipps-University, Marburg (Germany) where he got his PhD in biochemistry. In his thesis work he investigated the biosynthesis of plant organelles and enzymes of fatty acid metabolism. After a postdoctoral fellowship at the University of California, Berkeley (USA) he started his career in 1983 at the Battelle Institute in Frankfurt (Germany), an international contract research organization. He was responsible for all projects in biochemistry e.g. for development of detections methods and vaccines for bacterial toxins. In 1986 he became the section manager for cellular and molecular biology where his work was focused on genetic engineering and cell biology. Between 1995 and 2006 Dr Frevert was Project Manager for biochemical projects and later Chief Scientific Officer of BioteCon Therapeutics GmbH, and during this time he started a cooperation with Merz Pharmaceuticals to develop the pure clostridium botulinum neurotoxin as a pharmaceutical which was licensed as Xeomin in 2005 in Germany for the treatment of cervical dystonia and blepharospasm and in 2009 for the treatment of glabellar frown lines. In 2007 he was employed by Merz Pharmaceuticals as Head of Botulinum Toxin Research and was responsible for the development of next generation botulinum toxin products with new pharmacological properties. In 2017 he retired and is now working as a consultant for Merz Pharmaceuticals.
He has published widely in the scientific and medical literature and is a popular speaker at international congresses in the field of aesthetic medicine.
Merz Pharmaceuticals
Botulinum Toxin Research
Consultant
14473 Potsdam
Email: juergen.frevert@merz.de
Unsere Zertifizierer
